Veracyte, Inc.
VCYT
$32.13
$1.203.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 41.15M | 19.14M | -980.00K | 7.05M | 5.11M |
| Total Depreciation and Amortization | 5.30M | 5.27M | 5.49M | 5.36M | 6.25M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 658.00K | 13.97M | 27.87M | 8.34M | 17.00M |
| Change in Net Operating Assets | 5.48M | 6.38M | 1.23M | -15.39M | -3.85M |
| Cash from Operations | 52.58M | 44.76M | 33.61M | 5.36M | 24.52M |
| Capital Expenditure | -3.78M | -2.79M | -1.29M | -1.82M | -4.14M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -2.85M | -- | -- | -- | -- |
| Other Investing Activities | 1.20M | 51.06M | 1.06M | -50.00M | -50.00M |
| Cash from Investing | -5.43M | 48.26M | -224.00K | -51.82M | -54.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.51M | 5.79M | 1.81M | 2.97M | 3.26M |
| Repurchase of Common Stock | -3.66M | -2.81M | -2.38M | -9.45M | -3.27M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -4.50M |
| Cash from Financing | -149.00K | 2.98M | -566.00K | -6.48M | -4.51M |
| Foreign Exchange rate Adjustments | 12.00K | 60.00K | 573.00K | 74.00K | -401.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.02M | 96.06M | 33.39M | -52.87M | -34.53M |